A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study to compare the rate and extent of absorption of Actavis Group hf,
Iceland, finasteride and Merck & Co. Inc., U.S.A. (Proscar), finasteride, administered as a 1
x 5 mg tablet, under fasting conditions.